{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T08:35:59Z","timestamp":1787646959606,"version":"build-2736575974"},"reference-count":89,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100021041","name":"American College of Allergy, Asthma and Immunology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100021041","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.anai.2024.07.034","type":"journal-article","created":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T07:14:39Z","timestamp":1724483679000},"page":"110-121","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Food allergy yardstick"],"prefix":"10.1016","volume":"134","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6240-7437","authenticated-orcid":false,"given":"Aikaterini","family":"Anagnostou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Greenhawt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Shaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian P.","family":"Vickery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.anai.2024.07.034_bib0001","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1542\/peds.2011-0204","article-title":"The prevalence, severity, and distribution of childhood food allergy in the United States","volume":"128","author":"Gupta","year":"2011","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.anai.2024.07.034_bib0002","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.5630","article-title":"Prevalence and severity of food allergies among US adults","volume":"2","author":"Gupta","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"3","key":"10.1016\/j.anai.2024.07.034_bib0003","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s11882-023-01121-x","article-title":"Psychosocial impact of food allergy on children and adults and practical interventions","volume":"24","author":"Bingemann","year":"2024","journal-title":"Curr Allergy Asthma Rep"},{"issue":"3","key":"10.1016\/j.anai.2024.07.034_bib0004","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/ACI.0000000000000903","article-title":"A review of food allergy-related costs with consideration to clinical and demographic factors","volume":"23","author":"Golding","year":"2023","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.anai.2024.07.034_bib0005","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1177\/15248399231223740","article-title":"Food insecurity and psychosocial burden in a national community-based sample of households managing food allergy","volume":"25","author":"Sansweet","year":"2024","journal-title":"Health Promot Pract"},{"issue":"3","key":"10.1016\/j.anai.2024.07.034_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2024.100889","article-title":"The clinical burden of food allergies: insights from the Food Allergy Research & Education (FARE) Patient Registry","volume":"17","author":"Warren","year":"2024","journal-title":"World Allergy Organ J"},{"issue":"9","key":"10.1016\/j.anai.2024.07.034_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2022.100687","article-title":"Managing food allergy: GA(2)LEN guideline 2022","volume":"15","author":"Muraro","year":"2022","journal-title":"World Allergy Organ J"},{"issue":"4","key":"10.1016\/j.anai.2024.07.034_bib0008","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.iac.2021.07.012","article-title":"Diagnosis and management of food allergy","volume":"41","author":"Oriel","year":"2021","journal-title":"Immunol Allergy Clin North Am"},{"issue":"5","key":"10.1016\/j.anai.2024.07.034_bib0009","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.anai.2024.01.023","article-title":"Food allergies on a college campus","volume":"132","author":"Yuan","year":"2024","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"4","key":"10.1016\/j.anai.2024.07.034_bib0010","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s11882-024-01133-1","article-title":"The future of food allergy management: advancements in therapies","volume":"24","author":"Ezhuthachan","year":"2024","journal-title":"Curr Allergy Asthma Rep"},{"issue":"3","key":"10.1016\/j.anai.2024.07.034_bib0011","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jaci.2023.01.007","article-title":"The role of biologics in pediatric food allergy and eosinophilic gastrointestinal disorders","volume":"151","author":"Sindher","year":"2023","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2024.07.034_bib0012","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.jaip.2023.11.032","article-title":"The role of biologics in the treatment of food allergy","volume":"12","author":"Sindher","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"10","key":"10.1016\/j.anai.2024.07.034_bib0013","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1056\/NEJMoa2312382","article-title":"Omalizumab for the treatment of multiple food allergies","volume":"390","author":"Wood","year":"2024","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.anai.2024.07.034_bib0014","doi-asserted-by":"crossref","first-page":"e12064","DOI":"10.1002\/clt2.12064","article-title":"Incidence of anaphylaxis and accidental peanut exposure: a systematic review","volume":"11","author":"Muraro","year":"2021","journal-title":"Clin Transl Allergy"},{"issue":"9","key":"10.1016\/j.anai.2024.07.034_bib0015","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1136\/archdischild-2023-326225","article-title":"Addressing common questions on food oral immunotherapy: a practical guide for paediatricians","volume":"109","author":"Anagnostou","year":"2024","journal-title":"Arch Dis Child"},{"issue":"4","key":"10.1016\/j.anai.2024.07.034_bib0016","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1111\/all.16027","article-title":"Evaluation of clinical outcomes of efficacy in food allergen immunotherapy trials, COFAITH EAACI task force","volume":"79","author":"Del Rio","year":"2024","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.anai.2024.07.034_bib0017","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3390\/medicina60010121","article-title":"Food allergen immunotherapy in the treatment of patients with IgE-mediated food allergy","volume":"60","author":"Turkalj","year":"2024","journal-title":"Medicina (Kaunas)"},{"issue":"10187","key":"10.1016\/j.anai.2024.07.034_bib0018","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/S0140-6736(19)30420-9","article-title":"Oral immunotherapy for peanut allergy (PACE): a systematic review and meta-analysis of efficacy and safety","volume":"393","author":"Chu","year":"2019","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.anai.2024.07.034_bib0019","doi-asserted-by":"crossref","first-page":"e13888","DOI":"10.1111\/pai.13888","article-title":"Anaphylaxis during Peanut Oral Immunotherapy: looking beyond dose escalation","volume":"33","author":"Blackman","year":"2022","journal-title":"Pediatr Allergy Immunol"},{"issue":"1","key":"10.1016\/j.anai.2024.07.034_bib0020","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11882-022-01054-x","article-title":"Management of anaphylaxis during peanut oral immunotherapy","volume":"23","author":"Szafron","year":"2023","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.anai.2024.07.034_bib0021","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1056\/NEJMoa1812856","article-title":"AR101 oral immunotherapy for peanut allergy","volume":"379","author":"Vickery","year":"2018","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.anai.2024.07.034_bib0022","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jaip.2023.10.020","article-title":"Long-term follow-up of children who achieved sustained unresponsiveness after peanut oral immunotherapy","volume":"12","author":"Lee","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"10.1016\/j.anai.2024.07.034_bib0023","doi-asserted-by":"crossref","first-page":"259","DOI":"10.18176\/jiaci.0636","article-title":"Sustained unresponsiveness induced by oral immunotherapy is not a completely symptom-free condition: a prospective case series","volume":"31","author":"Bemanian","year":"2021","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2024.07.034_bib0024","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.jaci.2019.10.038","article-title":"Sustained successful peanut oral immunotherapy associated with low basophil activation and peanut-specific IgE","volume":"145","author":"Tsai","year":"2020","journal-title":"J Allergy Clin Immunol"},{"issue":"9925","key":"10.1016\/j.anai.2024.07.034_bib0025","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/S0140-6736(13)62301-6","article-title":"Assessing the efficacy of oral immunotherapy for the desensitisation of peanut allergy in children (STOP II): a phase 2 randomised controlled trial","volume":"383","author":"Anagnostou","year":"2014","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.anai.2024.07.034_bib0026","doi-asserted-by":"crossref","first-page":"e12225","DOI":"10.1002\/clt2.12225","article-title":"Peanut oral immunotherapy may improve health-related quality of life among severe peanut allergic adolescents","volume":"13","author":"Odling","year":"2023","journal-title":"Clin Transl Allergy"},{"issue":"12","key":"10.1016\/j.anai.2024.07.034_bib0027","doi-asserted-by":"crossref","first-page":"e12213","DOI":"10.1002\/clt2.12213","article-title":"Children and caregiver proxy quality of life from peanut oral immunotherapy trials","volume":"12","author":"Galvin","year":"2022","journal-title":"Clin Transl Allergy"},{"issue":"6","key":"10.1016\/j.anai.2024.07.034_bib0028","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/cea.14137","article-title":"Probiotic peanut oral immunotherapy is associated with long-term persistence of 8-week sustained unresponsiveness and long-lasting quality-of-life improvement","volume":"52","author":"Loke","year":"2022","journal-title":"Clin Exp Allergy"},{"issue":"2","key":"10.1016\/j.anai.2024.07.034_bib0029","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.anai.2020.03.028","article-title":"Quality of life improves significantly after real-world oral immunotherapy for children with peanut allergy","volume":"125","author":"Blackman","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"3","key":"10.1016\/j.anai.2024.07.034_bib0030","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.jaci.2010.12.1083","article-title":"Sublingual immunotherapy for peanut allergy: clinical and immunologic evidence of desensitization","volume":"127","author":"Kim","year":"2011","journal-title":"J Allergy Clin Immunol"},{"issue":"12","key":"10.1016\/j.anai.2024.07.034_bib0031","doi-asserted-by":"crossref","first-page":"921","DOI":"10.2217\/imt-2020-0123","article-title":"Sublingual immunotherapy for food allergy and its future directions","volume":"12","author":"Schworer","year":"2020","journal-title":"Immunotherapy"},{"issue":"1","key":"10.1016\/j.anai.2024.07.034_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2012.11.011","article-title":"Sublingual immunotherapy for peanut allergy: a randomized, double-blind, placebo-controlled multicenter trial","volume":"131","author":"Fleischer","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2024.07.034_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2014.12.1917","article-title":"Sublingual immunotherapy for peanut allergy: long-term follow-up of a randomized multicenter trial","volume":"135","author":"Burks","year":"2015","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.anai.2024.07.034_bib0034","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1016\/j.jaci.2023.01.036","article-title":"Open-label study of the efficacy, safety, and durability of peanut sublingual immunotherapy in peanut-allergic children","volume":"151","author":"Kim","year":"2023","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2024.07.034_bib0035","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jaci.2023.08.032","article-title":"Desensitization and remission after peanut sublingual immunotherapy in 1- to 4-year-old peanut-allergic children: a randomized, placebo-controlled trial","volume":"153","author":"Kim","year":"2024","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.anai.2024.07.034_bib0036","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s12016-024-08990-8","article-title":"From skin to solution: exploring epicutaneous immunotherapy for peanut allergy-a systematic review and meta-analysis","volume":"66","author":"Banatwala","year":"2024","journal-title":"Clin Rev Allergy Immunol"},{"issue":"6","key":"10.1016\/j.anai.2024.07.034_bib0037","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1080\/1744666X.2024.2315221","article-title":"Safety and efficacy of epicutaneous immunotherapy with DBV712 (peanut patch) in peanut allergy","volume":"20","author":"Dupont","year":"2024","journal-title":"Expert Rev Clin Immunol"},{"issue":"10","key":"10.1016\/j.anai.2024.07.034_bib0038","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1001\/jama.2019.1113","article-title":"Effect of epicutaneous immunotherapy vs placebo on reaction to peanut protein ingestion among children with peanut allergy: the PEPITES randomized clinical trial","volume":"321","author":"Fleischer","year":"2019","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.anai.2024.07.034_bib0039","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.jaci.2020.06.028","article-title":"Long-term, open-label extension study of the efficacy and safety of epicutaneous immunotherapy for peanut allergy in children: PEOPLE 3-year results","volume":"146","author":"Fleischer","year":"2020","journal-title":"J Allergy Clin Immunol"},{"issue":"19","key":"10.1016\/j.anai.2024.07.034_bib0040","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1056\/NEJMoa2212895","article-title":"Phase 3 trial of epicutaneous immunotherapy in toddlers with peanut allergy","volume":"388","author":"Greenhawt","year":"2023","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.anai.2024.07.034_bib0041","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jaip.2020.08.015","article-title":"Improvements in quality of life in children following epicutaneous immunotherapy (EPIT) for peanut allergy in the PEPITES and PEOPLE studies","volume":"9","author":"DunnGalvin","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"10322","key":"10.1016\/j.anai.2024.07.034_bib0042","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0140-6736(21)02390-4","article-title":"Efficacy and safety of oral immunotherapy in children aged 1-3 years with peanut allergy (the Immune Tolerance Network Impact trial): a randomised placebo-controlled study","volume":"399","author":"Jones","year":"2022","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.anai.2024.07.034_bib0043","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1056\/NEJMoa022613","article-title":"Effect of anti-IgE therapy in patients with peanut allergy","volume":"348","author":"Leung","year":"2003","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.anai.2024.07.034_bib0044","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.jaip.2022.11.036","article-title":"Omalizumab in IgE-mediated food allergy: a systematic review and meta-analysis","volume":"11","author":"Zuberbier","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"6","key":"10.1016\/j.anai.2024.07.034_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaip.2019.01.023","article-title":"Impact of omalizumab on food allergy in patients treated for asthma: a real-life study","volume":"7","author":"Fiocchi","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"5","key":"10.1016\/j.anai.2024.07.034_bib0046","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2011.01.051","article-title":"A phase II, randomized, double\u2011blind, parallel\u2011group, placebo\u2011controlled oral food challenge trial of Xolair (omalizumab) in peanut allergy","volume":"127","author":"Sampson","year":"2011","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.anai.2024.07.034_bib0047","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jacig.2022.05.006","article-title":"Protocol design and synopsis: omalizumab as monotherapy and as Adjunct Therapy to Multiallergen OIT in Children and Adults with Food Allergy (OUtMATCH)","volume":"1","author":"Wood","year":"2022","journal-title":"J Allergy Clin Immunol Glob"},{"key":"10.1016\/j.anai.2024.07.034_bib0048","unstructured":"Food and Drug Administration. Xolair package insert. Accessed May 22, 2024. Available at: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2021\/103976s5238lbl.pdf"},{"issue":"2","key":"10.1016\/j.anai.2024.07.034_bib0049","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.jaip.2019.09.037","article-title":"Estimation of health and economic benefits of clinic versus home administration of omalizumab and mepolizumab","volume":"8","author":"Shaker","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.anai.2024.07.034_bib0050","doi-asserted-by":"crossref","unstructured":"Shaker M, Anagnostou A, Abrams EM, Lee M, Conway AE, Blatman KSH, et al. The cost-effectiveness of omalizumab for treatment of food allergy [e-pub ahead of print]. J Allergy Clin Immunol Pract. https:\/\/doi.org\/10.1016\/j.jaip.2024.06.023. Accessed May 20, 2024.","DOI":"10.1016\/j.jaip.2024.06.023"},{"issue":"1","key":"10.1016\/j.anai.2024.07.034_bib0051","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jval.2015.09.2938","article-title":"The \u201cefficacy-effectiveness gap\u201d: historical background and current conceptualization","volume":"19","author":"Nordon","year":"2016","journal-title":"Value Health"},{"issue":"11","key":"10.1016\/j.anai.2024.07.034_bib0052","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2300145","article-title":"Oral immunotherapy for peanut allergy in children 1 to less than 4 years of age","volume":"2","author":"Du Toit","year":"2023","journal-title":"NEJM Evid"},{"issue":"4","key":"10.1016\/j.anai.2024.07.034_bib0053","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.jaci.2009.05.027","article-title":"Summary of the 2008 National Institute of Allergy and Infectious Diseases-US Food and Drug Administration workshop on food allergy clinical trial design","volume":"124","author":"Plaut","year":"2009","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.anai.2024.07.034_bib0054","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.jaip.2018.12.008","article-title":"Harmonization of terminology for tolerated and reactive dose in food allergy immunotherapy","volume":"7","author":"Casale","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"6","key":"10.1016\/j.anai.2024.07.034_bib0055","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.18162","article-title":"Racial, ethnic, and socioeconomic differences in food allergies in the US","volume":"6","author":"Jiang","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"2","key":"10.1016\/j.anai.2024.07.034_bib0056","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.iac.2021.01.007","article-title":"Racial\/ethnic differences in food allergy","volume":"41","author":"Warren","year":"2021","journal-title":"Immunol Allergy Clin North Am"},{"issue":"2","key":"10.1016\/j.anai.2024.07.034_bib0057","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jaci.2023.10.025","article-title":"Impact of socioeconomic factors on allergic diseases","volume":"153","author":"Perry","year":"2024","journal-title":"J Allergy Clin Immunol"},{"issue":"10","key":"10.1016\/j.anai.2024.07.034_bib0058","doi-asserted-by":"crossref","first-page":"3348","DOI":"10.1016\/j.jaip.2020.07.035","article-title":"AAAAI work group report: trends in oral food challenge practices among allergists in the United States","volume":"8","author":"Greiwe","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"5","key":"10.1016\/j.anai.2024.07.034_bib0059","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.jaci.2014.05.013","article-title":"Food allergy: a practice parameter update-2014","volume":"134","author":"Sampson","year":"2014","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.anai.2024.07.034_bib0060","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.jaci.2020.07.031","article-title":"Peanut allergy diagnosis: a 2020 practice parameter update, systematic review, and GRADE analysis","volume":"146","author":"Greenhawt","year":"2020","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.anai.2024.07.034_bib0061","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.anai.2018.06.018","article-title":"Understanding caregiver goals, benefits, and acceptable risks of peanut allergy therapies","volume":"121","author":"Greenhawt","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"9","key":"10.1016\/j.anai.2024.07.034_bib0062","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1111\/all.15323","article-title":"Psychometric parameters of food allergy quality of life during an allergen immunotherapy trial","volume":"77","author":"Coelho GL de","year":"2022","journal-title":"Allergy"},{"issue":"8","key":"10.1016\/j.anai.2024.07.034_bib0063","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1111\/pai.13604","article-title":"Deriving health utility indices from a food allergy quality-of-life questionnaire","volume":"32","author":"Chen","year":"2021","journal-title":"Pediatr Allergy Immunol"},{"issue":"2","key":"10.1016\/j.anai.2024.07.034_bib0064","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.anai.2019.05.012","article-title":"A primer on cost-effectiveness in the allergy clinic","volume":"123","author":"Shaker","year":"2019","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2024.07.034_bib0065","doi-asserted-by":"crossref","unstructured":"Stephen E, Conway AE, Codispoti CD, Abrams E, Lieberman JA, Ledford D, et al. Patient-centered practice guidelines: GRADEing evidence to incorporate certainty, balance between benefits and harms, equity, feasibility, and cost-effectiveness [e-pub ahead of print]. J Allergy Clin Immunol Pract. https:\/\/doi.org\/10.1016\/j.jaip.2024.03.008. Accessed May 20, 2024.","DOI":"10.1016\/j.jaip.2024.03.008"},{"issue":"5","key":"10.1016\/j.anai.2024.07.034_bib0066","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.jaip.2017.06.031","article-title":"Fatal anaphylaxis: mortality rate and risk factors","volume":"5","author":"Turner","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.anai.2024.07.034_bib0067","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jaip.2021.05.021","article-title":"Managing food allergy when the patient is not highly allergic","volume":"10","author":"Sicherer","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"10.1016\/j.anai.2024.07.034_bib0068","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/ACI.0000000000000271","article-title":"Food allergy quality of life and living with food allergy","volume":"16","author":"Greenhawt","year":"2016","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2024.07.034_bib0069","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1159\/000375106","article-title":"The effects of food allergy on quality of life","volume":"101","author":"DunnGalvin","year":"2015","journal-title":"Chem Immunol Allergy"},{"issue":"4","key":"10.1016\/j.anai.2024.07.034_bib0070","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/MOP.0000000000000509","article-title":"An update on the impact of food allergy on anxiety and quality of life","volume":"29","author":"Shaker","year":"2017","journal-title":"Curr Opin Pediatr"},{"issue":"5","key":"10.1016\/j.anai.2024.07.034_bib0071","doi-asserted-by":"crossref","first-page":"290","DOI":"10.2500\/aap.2019.40.4240","article-title":"Peanut allergy: burden of illness","volume":"40","author":"Shaker","year":"2019","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.anai.2024.07.034_bib0072","article-title":"Fear of injections and needle phobia among children and adolescents: an overview of psychological, behavioral, and contextual factors","volume":"4","author":"Orenius","year":"2018","journal-title":"SAGE Open Nurs"},{"issue":"11","key":"10.1016\/j.anai.2024.07.034_bib0073","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0276814","article-title":"Prevalence, causes, impacts, and management of needle phobia: an international survey of a general adult population","volume":"17","author":"Alsbrooks","year":"2022","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.anai.2024.07.034_bib0074","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12969-020-0406-6","article-title":"Children's fear of needle injections: a qualitative study of training sessions for children with rheumatic diseases before home administration","volume":"18","author":"Sorensen","year":"2020","journal-title":"Pediatr Rheumatol Online J"},{"issue":"2","key":"10.1016\/j.anai.2024.07.034_bib0075","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/bjc.12345","article-title":"A comprehensive group-based cognitive behavioural treatment for blood-injection-injury phobia","volume":"61","author":"Mason","year":"2022","journal-title":"Br J Clin Psychol"},{"issue":"6","key":"10.1016\/j.anai.2024.07.034_bib0076","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0253048","article-title":"The prevalence and evidence-based management of needle fear in adults with chronic disease: a scoping review","volume":"16","author":"Duncanson","year":"2021","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.anai.2024.07.034_bib0077","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2500\/jfa.2023.5.230001","article-title":"Shared decision-making, communicating risk, and food allergy in 2023","volume":"5","author":"Shaker","year":"2023","journal-title":"J Food Allergy"},{"issue":"3","key":"10.1016\/j.anai.2024.07.034_bib0078","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.jaip.2020.10.009","article-title":"Cost-effectiveness of biologics for allergic diseases","volume":"9","author":"Wu","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"5","key":"10.1016\/j.anai.2024.07.034_bib0079","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.jaip.2024.02.039","article-title":"Pharmacoequity and biologics in the allergy clinic: providing the right care, at the right time, every time, to everyone","volume":"12","author":"Conway","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"10.1016\/j.anai.2024.07.034_bib0080","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s11882-024-01132-2","article-title":"A review of shared decision-making, published protocols, and post-desensitization strategies in oral immunotherapy (OIT)","volume":"24","author":"Laubach","year":"2024","journal-title":"Curr Allergy Asthma Rep"},{"issue":"8","key":"10.1016\/j.anai.2024.07.034_bib0081","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1016\/j.jaip.2020.07.003","article-title":"The challenges and opportunities for shared decision making highlighted by COVID-19","volume":"8","author":"Abrams","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"5","key":"10.1016\/j.anai.2024.07.034_bib0082","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.anai.2018.08.019","article-title":"Shared decision making for the allergist","volume":"122","author":"Blaiss","year":"2019","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"6","key":"10.1016\/j.anai.2024.07.034_bib0083","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1016\/j.jaip.2023.03.024","article-title":"Viewing pediatric food oral immunotherapy through an ethical lens-a narrative systematic review","volume":"11","author":"Bjelac","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"6","key":"10.1016\/j.anai.2024.07.034_bib0084","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.anai.2020.03.009","article-title":"Making the GRADE in anaphylaxis management: toward recommendations integrating values, preferences, context, and shared decision making","volume":"124","author":"Shaker","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"6","key":"10.1016\/j.anai.2024.07.034_bib0085","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1080\/1744666X.2023.2201438","article-title":"Food immunotherapy: current status and future needs","volume":"19","author":"Anagnostou","year":"2023","journal-title":"Expert Rev Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2024.07.034_bib0086","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/cea.13742","article-title":"Food immunotherapy: choosing wisely","volume":"51","author":"Anagnostou","year":"2021","journal-title":"Clin Exp Allergy"},{"issue":"3","key":"10.1016\/j.anai.2024.07.034_bib0087","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.anai.2020.05.031","article-title":"Shared decision-making in the care of a patient with food allergy","volume":"125","author":"Greenhawt","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"10.1016\/j.anai.2024.07.034_bib0088","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.anai.2020.01.030","article-title":"Development and acceptability of a shared decision-making tool for commercial peanut allergy therapies","volume":"125","author":"Greenhawt","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2024.07.034_bib0089","article-title":"Identification of goals and barriers to treatment from 92 consecutive consultations with families considering peanut oral immunotherapy","volume":"7","author":"Blackman","year":"2019","journal-title":"Ther Adv Vaccines Immunother"}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120624004940?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120624004940?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T22:34:35Z","timestamp":1786487675000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120624004940"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":89,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S1081120624004940"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2024.07.034","relation":{},"ISSN":["1081-1206"],"issn-type":[{"value":"1081-1206","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Food allergy yardstick","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2024.07.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}